• Bennett, J.M., Kaminski, M.S., Leonard, J.P., Vose, J.M., Zelenetz, A.D., Knox, S.J., Horning, S., Press, O.W., Radford, J., Kroll, S.M. & Capizzi, R.L. (2005) Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukaemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine131I tositumomab. Blood, 105, 45764582.
  • McLaughlin, P., Estey, E., Glassman, A., Romaguera, J., Samaniego, F., Ayala, A., Hayes, K., Maddox, A.M., Preti, H.A. & Hagemeister, F.B. (2005) Myelodysplasia and acute myeloid leukaemia following therapy for indolent lymphoma with fludarabine, mitoxantrone and dexamethasone (FND) plus rituximab and interferon alpha. Blood, 105, 45734575.
  • Milligan, D.W., Kochethu, G., Dearden, C., Matutes, E., MacConkey, C. & Catovsky, D. (2006) High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council pilot of autografting in chronic lymphocytic leukaemia. British Journal of Haematology, 133, 173175.
  • Morrison, V.A., Rai, K.R., Peterson, B.L., Kolitz, J.E., Elias, L., Appelbaum, F.R., Hines, J.D., Shepherd, L., Larson, R.A. & Schiffer, C.A. (2002) Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukaemia after treatment with fludarabine and chlorambucil: results of an Intergroup Study, Cancer and Leukemia Group B 9011. Journal of Clinical Oncology, 20, 38783884.
  • Pedersen-Bjergaard, J. & Andersen, M.K. (2001) Therapy-related myelodysplasia and acute myeloid leukaemia risk and chromosome abnormalities. ASCO Educational Book Spring, 566577.
  • Pedersen-Bjergaard, J., Specht, L., Larsen, S.O., Ersboll, J., Struck, J., Hansen, M.M., Hansen, H.H. & Nissen, N.I. (1987) Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. The Lancet, 2, 8388.